Lack of association between the incidence of testicular germ cell tumors and Y-chromosome haplogroups in the Japanese population

International Journal of Urology

Volumn 13, Issue 9, 2006, Pages 1212-1217

  Ewis, Ashraf A ^a,d   Lee, Juwon ^b   Naroda, Takushi ^c   Kagawa, Susumu ^c   Baba, Yoshinobu ^a,b   Nakahori, Yutaka ^b  

^a NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

^b UNIVERSITY OF TOKUSHIMA   (Japan)

^c UNIVERSITY OF TOKUSHIMA   (Japan)

^d Minia University   (Egypt)

Author keywords

Binary polymorphisms; Haplogroups; Suceptibility; Testicular germ cell tumors; Y chromosome lineages

Indexed keywords

ADULT; ARTICLE; CARCINOGENESIS; CHROMOSOME POLYMORPHISM; CONTROL GROUP; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; GENETIC ANALYSIS; GENETIC MARKER; GENETIC VARIABILITY; GEOGRAPHIC DISTRIBUTION; GERM CELL TUMOR; HAPLOTYPE; HUMAN; HYPOTHESIS; INCIDENCE; JAPAN; MAJOR CLINICAL STUDY; MALE; POPULATION STRUCTURE; PRIORITY JOURNAL; TESTIS CANCER; Y CHROMOSOME;

ADULT; CASE-CONTROL STUDIES; CHROMOSOMES, HUMAN, Y; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; INCIDENCE; JAPAN; MALE; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; SEMINOMA; TESTICULAR NEOPLASMS;

EID: 33748777373     PISSN: 09198172     EISSN: 14422042     Source Type: Journal    
DOI: 10.1111/j.1442-2042.2006.01527.x     Document Type: Article

References (33)

1. Jemal A, Murray T, Ward E et al. Cancer statistics, 2005. CA Cancer J. Clin. 2005; 55: 10-30.
2. Bergstrom R, Adami HO, Mohner M et al. Increase in testicular cancer incidence in six European countries: a birth cohort phenomenon. J. Natl. Cancer Inst. 1996; 88: 727-33.
3. Zheng T, Holford TR, Ma Z, Ward BA, Flannery J, Boyle P. Continuing increase in incidence of germ-cell testis cancer in young adults: experience from Connecticut, USA, 1935-1992. Int. J. Cancer 1996; 65: 723-9.
4. Einhorn LH. Chemotherapeutic and surgical strategies for germ cell tumors. Chest Surg. Clin. N. Am. 2002; 12: 695-06.
5. Moller H. Trends in sex-ratio, testicular cancer and male reproductive hazards: are they connected? APMIS 1998; 106: 232-8.
6. Petersen PM, Skakkebaek NE, Giwercman A. Gonadal function in men with testicular cancer: biological and clinical aspects. APMIS 1998; 106: 24-34.
7. Moller H, Skakkebaek NE. Risk of testicular cancer in subfertile men: case-control study. BMJ 1999; 318: 559-62.
8. McElreavey K, Krausz C, Bishop CE. The human Y chromosome and male infertility. Results Probl. Cell Differ. 2000; 28: 211-32.
9. Jobling MA, Tyler-Smith C. New uses for new haplotypes the human Y chromosome, disease and selection. Trends Genet. 2000; 16: 356-62.
10. McElreavey K, Quintana-Murci L. Y chromosome haplogroups: a correlation with testicular dysgenesis syndrome? APMIS 2003; 111: 106-13.
11. Jacobsen R, Bostofte E, Engholm G, Hansen J, Skakkebaek NE, Moller H. Fertility and offspring sex ratio of men who develop testicular cancer: a record linkage study. Hum. Reprod. 2000; 15: 1958-61.
12. Schuz J, Schon D, Batzler W et al. Cancer registration in Germany: current status, perspectives and trends in cancer incidence 1973-1993. J. Epidemiol. Biostat. 2000; 5: 99-107.
13. Quintana-Murci L, Weale ME, Thomas MG et al. Y chromosome haplotypes and testicular cancer in the English population. J. Med. Genet. 2003; 40: e20.
14. Sambrook F, Fritsch EF, Maniathis T. Molecular Cloning. A Laboratoty Manual, 2nd edn. Cold Spring Harbor Laboratory Press, New York, 1989.
15. Kuroki Y, Iwamoto T, Lee JW et al. Spermatogenic ability is different among males in different Y chromosome lineage. J. Hum. Genet. 1999; 44: 289-92.
16. Shinka T, Tomita K, Toda T et al. Genetic variations on the Y chromosome in the Japanese population and implications for modern human Y chromosome lineage. J. Hum. Genet. 1999; 44: 240-5.
17. Anon. Y chromosome consortium, (YCC). A nomenclature system for the tree of human Y-chromosomal binary haplogroups. Genome Res. 2002; 12: 339-48.
18. Lam MY, Nadeau JH. Genetic control of susceptibility to spontaneous testicular germ cell tumors in mice. APMIS 2003; 111: 184-90.
19. Raghavan D, Jelihovsky T, Fox RM. Father-son testicular malignancy. Does genetic anticipation occur? Cancer 1980; 45: 1005-9.
20. Patel SR, Kvols LK, Richardson RL. Familial testicular cancer: report of six cases and review of the literature. Mayo Clin. Proc. 1990; 65: 804-8.
21. von der Maase H, Rorth M, Walbom-Jorgensen S et al. Carcinoma in situ of contralateral testis in patients with testicular germ cell cancer: study of 27 cases in 500 patients. Br. Med. J. (Clin. Res. Ed.) 1986; 293: 1398-401.
22. Colls BM, Harvey VJ, Shalton L, Thompson PI, Frampton CM. Bilateral germ cell testicular tumors in New Zealand: experience Auckland and Christchurch. J. Clin. Oncol. 1996; 7: 2061-5.
23. Sonnenveld DJA, Schraffordt Koops H, Sleijfer DT, Hoekstra HJ. Bilateral testicular tumors in patients with initial stage I disease: prevalence and prognosis: a single centres 30 years' experience. Eur. J. Cancer 1998; 34: 1363-7.
24. Forman D, Oliver RTD, Brett AR et al. Familial testicular cancer: a report of the UK family register, estimation of risk and an HLA class 1 sib-pair analysis. Br. J. Cancer 1992; 65: 255-62.
25. Oliver RTD. Current opinion in cancer 2000. Curr. Opin. Oncol. 2000; 12: 249-54.
26. Tsuchiya K, Reijo R, Page DC, Disteche CM. Gonadoblastoma: molecular definition of the susceptibility region on the Y chromosome. Am. J. Hum. Genet. 1995; 57: 1400-7.
27. Lau YF. Gonadoblastoma, testicular and prostate cancers, and the TSPY gene. Am. J. Hum. Genet. 1999; 64: 921-7.
28. Schnieders F, Dork T, Arnemann J, Vogel T, Werner M, Schmidtke J. Testis-specific protein, Y-encoded (TSPY) expression in testicular tissues. Hum. Mol. Genet. 1996; 5: 1801-7.
29. Yuan X, Lu ML, Li T, Balk SP. SRY interacts with and negatively regulates androgen receptor transcriptional activity. J. Biol. Chem. 2001; 276: 46647-54.
30. Suzuki H, Ueda T, Ichikawa T, Ito H. Androgen receptor involvement in the progression of prostate cancer. Endocr. Relat. Cancer 2003; 10: 209-16.
31. Hammer MF, Horai S. Y chromosomal DNA variation and the peopling of Japan. Am. J. Hum. Genet. 1995; 56: 951-62.
32. Ewis AA, Lee J, Naroda T et al. Linkage between prostate cancer incidence and different alleles of the human Y-linked tetranucleotide polymorphism DYS19. J. Med. Invest. 2002; 49: 56-60.
33. Ewis AA, Lee J, Shinka T, Nakahori Y. Microdeletions of a Y-specific marker, Yfm1, and implications for a role in spermatogenesis. J. Hum. Genet. 2002; 47: 257-61.